Stage IVB Prostate Cancer AJCC v8 Recruiting Phase 2 Trials for Niraparib (DB11793)

IndicationStatusPhase
DBCOND0109404 (Stage IVB Prostate Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05689021CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene MutationsTreatment